During his two years at Mass General, Mr. Eldredge oversaw the creation and execution of strategy and growth initiatives. He has also held a variety of executive roles at other healthcare and pharmaceutical companies, according to the July 14 press release.
He joins PathAI, a provider of AI-powered research tools for pathology that aims to improve the diagnosis and treatment of diseases.
“Brandon’s finance experience spans strategy, business development, mergers and acquisitions, and partnerships for a wide range of high-growth healthcare and technology organizations,” said Andy Beck, co-founder and CEO of PathAI. “By adding him to our growing leadership team, we have positioned PathAI for the next phase of growth that will allow us to accelerate our mission of improving patient outcomes with AI-powered pathology.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
